This website is a preview of our work. Our treatment remains in research and development while we address the challenges that must be resolved before we can offer it.
Update — December 22, 2025: It has been an eventful year, and we are closer to our goal than ever before. Check back regularly for news.
We'd love to hear from you!
We'd love to hear from you!
Our Location
CEO:
Thomas Rogg
Register:
Delaware, USA, # 68520
